Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fëllanza Ismajli-Hoxha"'
Publikováno v:
International Journal of Biomedicine, Vol 14, Iss 4, Pp 626-631 (2024)
Background: Glaucoma is a progressive optic nerve disease that, despite its treatment, is associated with retinal ganglion cell damage. However, timely treatment hinders the progression of visual field damage and preserves visual function. Our study
Externí odkaz:
https://doaj.org/article/c6da244b701348d98d4459ef9ae679de
Publikováno v:
International Journal of Biomedicine, Vol 14, Iss 4, Pp 621-625 (2024)
Background: Glaucoma is a progressive disease that requires lifelong treatment to maintain visual function. Elevated intraocular pressure (IOP) is considered the most important treatable risk factor for disease development and progression. The presen
Externí odkaz:
https://doaj.org/article/269edb45892b4643b624f7c298341c93
Publikováno v:
Open Journal of Ophthalmology. :176-183
Purpose: To compare intraocular pressure (IOP)-lowering efficacy and safety of travoprost 0.004% and travoprost 0.004% and beta-blocker 0.5% fixed combination ophthalmic solution in patients with open-angle glaucoma and ocular hypertension. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e3afe5b575ee8714601d27b60d2299a
https://doi.org/10.4236/ojoph.2017.73024
https://doi.org/10.4236/ojoph.2017.73024
Publikováno v:
Spektrum der Augenheilkunde. 27(5):239-244
To compare intraocular pressure (IOP)-lowering efficacy of prostaglandin analogue, beta-blocker and prostaglandin analogue/beta-blocker fixed combination ophthalmic solution in patients with open-angle glaucoma. In this prospective, multicentre, rand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7faa4e79233a5ff8c00c5a79d6a79008